These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 34013817)

  • 1. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
    Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
    Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin CD4
    Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
    J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.
    Vazquez T; Patel J; Kodali N; Diaz D; Bashir MM; Chin F; Keyes E; Sharma M; Sprow G; Grinnell M; Dan J; Werth VP
    J Invest Dermatol; 2024 Jun; 144(6):1262-1272.e7. PubMed ID: 38086428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
    Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
    J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
    Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
    Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced CCR5+/CCR3+ T helper cell ratio in patients with active cutaneous lupus erythematosus.
    Freutel S; Gaffal E; Zahn S; Bieber T; Tüting T; Wenzel J
    Lupus; 2011 Oct; 20(12):1300-4. PubMed ID: 21844117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
    Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
    J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interleukin-17 is correlated with interferon-α expression in cutaneous lesions of lupus erythematosus.
    Oh SH; Roh HJ; Kwon JE; Lee SH; Kim JY; Choi HJ; Lim BJ
    Clin Exp Dermatol; 2011 Jul; 36(5):512-20. PubMed ID: 21631571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
    Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
    Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.
    Wenzel J; Uerlich M; Wörrenkämper E; Freutel S; Bieber T; Tüting T
    Br J Dermatol; 2005 Nov; 153(5):1011-5. PubMed ID: 16225615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
    Braunstein I; Klein R; Okawa J; Werth VP
    Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.
    Abernathy-Close L; Lazar S; Stannard J; Tsoi LC; Eddy S; Rizvi SM; Yee CM; Myers EM; Namas R; Lowe L; Reed TJ; Wen F; Gudjonsson JE; Kahlenberg JM; Berthier CC
    Front Immunol; 2021; 12():775353. PubMed ID: 34868043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.
    Lai C; Coltart G; Shapanis A; Healy C; Alabdulkareem A; Selvendran S; Theaker J; Sommerlad M; Rose-Zerilli M; Al-Shamkhani A; Healy E
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The classification and diagnosis of cutaneous lupus erythematosus.
    Kuhn A; Landmann A
    J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
    Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological characteristics of patients with cutaneous lupus erythematosus.
    Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P
    Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials.
    Zeidi M; Chen KL; Patel J; Desai K; Kim HJ; Chakka S; Lim R; Werth VP
    Lupus; 2022 Apr; 31(4):472-481. PubMed ID: 35258358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXP3+ and CD39+ regulatory T cells in subtypes of cutaneous lupus erythematosus.
    Gambichler T; Pätzholz J; Schmitz L; Lahner N; Kreuter A
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1972-7. PubMed ID: 25808110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of
    Gardet A; Pellerin A; McCarl CA; Diwanji R; Wang W; Donaldson D; Franchimont N; Werth VP; Rabah D
    Front Immunol; 2019; 10():275. PubMed ID: 30846987
    [No Abstract]   [Full Text] [Related]  

  • 20. Apoptosis of keratinocytes and serum DNase I activity in patients with cutaneous lupus erythematosus: relationship with clinical and immunoserological parameters.
    Skiljevic D; Bonaci-Nikolic B; Brasanac D; Nikolic M
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):523-529. PubMed ID: 27557471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.